Bayesian piecewise mixture model for racial disparity in prostate cancer progression

Racial differences in prostate cancer incidence and mortality have been reported. Several authors hypothesize that African Americans have a more rapid growth rate of prostate cancer compared to Caucasians, that manifests in higher recurrence and lower survival rates in the former group. In this paper we propose a Bayesian piecewise mixture model to characterize PSA progression over time in African Americans and Caucasians, using follow-up serial PSA measurements after surgery. Each individual's PSA trajectory is hypothesized to have a latent phase immediately following surgery followed by a rapid increase in PSA indicating regrowth of the tumor. The true time of transition from the latent phase to the rapid growth phase is unknown, and can vary across individuals, suggesting a random change point across individuals. Furthermore, some patients may not experience the latent phase due to the cancer having already spread outside the prostate before undergoing surgery. We propose a two-component mixture model to accommodate patients both with and without a latent phase. Within the framework of this mixture model, patients who do not have a latent phase are allowed to have different rates of PSA rise; patients who have a latent phase are allowed to have different PSA trajectories, represented by subject-specific change points and rates of PSA rise before and after the change point. The proposed Bayesian methodology is implemented using Markov Chain Monte Carlo techniques. Model selection is performed using deviance information criteria based on the observed and complete likelihoods. Finally, we illustrate the methods using a prostate cancer dataset.

[1]  K Ulm,et al.  A statistical method for assessing a threshold in epidemiological studies. , 1991, Statistics in medicine.

[2]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[3]  R. Abdi,et al.  Correlation between glomerular size and long-term renal function in patients with substantial loss of renal mass. , 2003, The Journal of urology.

[4]  A. Renshaw,et al.  Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era. , 2003, The Journal of urology.

[5]  C. Robert,et al.  Deviance information criteria for missing data models , 2006 .

[6]  M. Terris,et al.  Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. , 2003, Urology.

[7]  Larry C. Clark,et al.  Using PSA to detect prostate cancer onset: An application of Bayesian retrospective and prospective changepoint identification , 1999 .

[8]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[9]  M. Barry,et al.  Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. , 1996, Journal of the National Cancer Institute.

[10]  J. Moul,et al.  Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. , 1996, The Journal of urology.

[11]  Lindsey A. Torre,et al.  Cancer Facts and Figures for Hispanics/Latinos 2015-2017 , 1905 .

[12]  Yeow Meng Thum,et al.  Detecting a Change in School Performance: A Bayesian Analysis for a Multilevel Join Point Problem , 2001 .

[13]  M. Iorio Discussion to the paper by Spiegelhalter et al., “Bayesian measures of complexity and fit” , 2002 .

[14]  T R Holford,et al.  Change points in the series of T4 counts prior to AIDS. , 1995, Biometrics.

[15]  Lynn Kuo,et al.  Bayesian and profile likelihood change point methods for modeling cognitive function over time , 2003, Comput. Stat. Data Anal..

[16]  Dale McLerran,et al.  An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. , 1993, JAMA.

[17]  A. Pollack,et al.  Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer , 1994, Cancer.

[18]  James A Hanley,et al.  Hierarchical changepoint models for biochemical markers illustrated by tracking postradiotherapy prostate-specific antigen series in men with prostate cancer. , 2008, Annals of epidemiology.

[19]  Andrew Thomas,et al.  WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..

[20]  C. Robert,et al.  Computational and Inferential Difficulties with Mixture Posterior Distributions , 2000 .

[21]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[22]  M. Banerjee,et al.  Should African‐American men be tested for prostate carcinoma at an earlier age than white men? , 1999, Cancer.